Relmada Therapeutics, Inc. (TRADEGATE:4E2) Financings
Financings
| Raise | Date |
|---|---|
| Public offering of common stock and pre-funded warrants Announced: about US$100M · US$2.2 a share · Jefferies +2 Dealers: Jefferies (co-lead), Leerink Partners (co-lead), Mizuho Buyers: Janus Henderson Investors; Ferring Ventures SA; Squadron Capital Management; Marshall Wace; Spruce Street Capital; OrbiMed; Columbia Threadneedle Investments; Driehaus Capital Management Use of proceeds: Working capital and general corporate purposes, including clinical studies and further development of product candidates | Nov 4, 2025 |